Abstract
Purpose of Review: In recent decades, food allergy has become an increasing concern for families, clinicians, and policymakers. This review aims to summarize what is currently known about the epidemiology and population-level burden of IgE-mediated food allergy, including its effects on quality of life. Recent Findings: Prevalence surveys, healthcare utilization data, and findings from longitudinal cohort studies across the globe indicate that food allergy imposes a growing societal burden. Worryingly, recent data indicate that food allergies may be more prevalent among adult populations than previously acknowledged, with many reported cases of adult-onset allergies. Summary: While it remains unclear how much of the current population-level burden of disease results from true, IgE-mediated allergy, as much epidemiological data does not incorporate clinical confirmation of disease prevalence—it is clear that affected individuals suffer impairments in their quality of life and incur substantial economic costs—beyond the physical health burden imposed by anaphylaxis.
Original language | English (US) |
---|---|
Article number | 6 |
Journal | Current allergy and asthma reports |
Volume | 20 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2020 |
Funding
Dr. Gupta reports grants from The National Institute of Health (NIH), grants from Rho Inc., grants from Stanford Sean N. Parker Center for Allergy Research, grants from United Health Group, grants from Thermo Fisher Scientific, grants from Genentech, grants from National Confectioners Association, personal fees from Before Brands, personal fees from Kaléo Inc., personal fees from Genentech, personal fees from ICER, personal fees from FARE, personal fees from Aimmune Therapeutics, and personal fees from DBV Technologies, outside the submitted work.
Keywords
- Burden of disease
- Food allergy epidemiology
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Pulmonary and Respiratory Medicine